IE851103L - 2-oxindoles. - Google Patents

2-oxindoles.

Info

Publication number
IE851103L
IE851103L IE851103A IE110385A IE851103L IE 851103 L IE851103 L IE 851103L IE 851103 A IE851103 A IE 851103A IE 110385 A IE110385 A IE 110385A IE 851103 L IE851103 L IE 851103L
Authority
IE
Ireland
Prior art keywords
oxindoles
bg60207b2
pyridile
furylmethyl
thienylmethyl
Prior art date
Application number
IE851103A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IE851103L publication Critical patent/IE851103L/xx
Priority to IE3064/89A priority Critical patent/IE57852B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/34—Oxygen atoms in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IE851103A 1984-05-04 1985-05-02 2-oxindoles. IE851103L (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IE3064/89A IE57852B1 (en) 1984-05-04 1989-09-25 N-substituted 2-oxindole-1-carboxamide intermediates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60735684A 1984-05-04 1984-05-04

Publications (1)

Publication Number Publication Date
IE851103L true IE851103L (en) 1985-11-04

Family

ID=24431933

Family Applications (1)

Application Number Title Priority Date Filing Date
IE851103A IE851103L (en) 1984-05-04 1985-05-02 2-oxindoles.

Country Status (25)

Country Link
JP (1) JPS60243068A (OSRAM)
KR (1) KR870000497B1 (OSRAM)
AR (1) AR241159A1 (OSRAM)
BG (2) BG60208B2 (OSRAM)
CS (1) CS252828B2 (OSRAM)
DD (1) DD232916A5 (OSRAM)
EG (1) EG17193A (OSRAM)
ES (2) ES8609248A1 (OSRAM)
FI (1) FI80016C (OSRAM)
HU (1) HU196057B (OSRAM)
IE (1) IE851103L (OSRAM)
IN (1) IN161509B (OSRAM)
MA (1) MA20424A1 (OSRAM)
MW (1) MW1685A1 (OSRAM)
MX (1) MX5839A (OSRAM)
NO (1) NO163132C (OSRAM)
OA (1) OA08098A (OSRAM)
PL (2) PL147508B1 (OSRAM)
PT (1) PT80375B (OSRAM)
RO (2) RO94455B (OSRAM)
RU (1) RU2017729C1 (OSRAM)
SU (1) SU1468413A3 (OSRAM)
YU (1) YU44998B (OSRAM)
ZA (1) ZA853324B (OSRAM)
ZW (1) ZW7885A1 (OSRAM)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives
IL95880A (en) * 1989-10-13 1995-12-31 Pfizer Use of 3-Transformed History of 2-Oxindole for the Preparation of Pharmaceuticals for Inhibition of Interlaukio-1 Biosynthesis

Also Published As

Publication number Publication date
RO94455A (ro) 1988-06-30
FI851756L (fi) 1985-11-05
KR850008154A (ko) 1985-12-13
OA08098A (fr) 1987-03-31
RO91141B (ro) 1987-07-03
KR870000497B1 (ko) 1987-03-12
NO851774L (no) 1985-11-05
EG17193A (en) 1990-08-30
FI80016B (fi) 1989-12-29
RO91141A (ro) 1987-06-30
SU1468413A3 (ru) 1989-03-23
MX5839A (es) 1993-11-01
CS252828B2 (en) 1987-10-15
AR241159A1 (es) 1991-12-30
NO163132B (no) 1990-01-02
YU73085A (en) 1988-04-30
PL253203A1 (en) 1986-06-17
BG60207B2 (en) 1993-12-30
PL145416B1 (en) 1988-09-30
CS320285A2 (en) 1987-03-12
PL147508B1 (en) 1989-06-30
BG60208B2 (en) 1993-12-30
JPS60243068A (ja) 1985-12-03
JPH0335315B2 (OSRAM) 1991-05-27
ES551275A0 (es) 1987-07-16
RU2017729C1 (ru) 1994-08-15
ES542813A0 (es) 1986-07-16
FI80016C (fi) 1990-04-10
HU196057B (en) 1988-09-28
AR241159A2 (es) 1991-12-30
RO94455B (ro) 1988-07-01
IN161509B (OSRAM) 1987-12-19
PT80375A (en) 1985-05-01
MW1685A1 (en) 1986-09-10
PT80375B (pt) 1987-09-30
MA20424A1 (fr) 1985-12-31
HUT37754A (en) 1986-02-28
YU44998B (en) 1991-06-30
ES8609248A1 (es) 1986-07-16
ZA853324B (en) 1986-12-30
DD232916A5 (de) 1986-02-12
PL257892A1 (en) 1986-10-07
NO163132C (no) 1990-04-11
ES8707182A1 (es) 1987-07-16
FI851756A0 (fi) 1985-05-03
ZW7885A1 (en) 1985-07-24

Similar Documents

Publication Publication Date Title
IE873449L (en) 3-aryloxypropanamine derivatives
IE800021L (en) Piperidinylalkyl quinazolines
KR860009010A (ko) 티아졸리딘디온의 제조방법
ES8102107A1 (es) Un procedimiento para la obtencion de un derivado de tiazo- lidina
KR830007597A (ko) 3-아릴-5-이소티아졸 유도체의 제조방법
ES482281A1 (es) Un procedimiento para la prepracion de 2,3,4,5-tetrahidro- 1h-37benzazepinas mercapto-substituidas.
KR840008001A (ko) 티아졸리딘 유도체의 제조방법
IE41528L (en) Furfuryl-benzomorphane derivatives.
JPS53108947A (en) Substituted phenylurea derivative, its production and selective herbicide containing the same
IE791339L (en) Derivatives of 19-nor-3,20-diketosteroids
ES8609272A1 (es) Un procedimiento para preparar derivados de hidantoina
IE800688L (en) Xanthine derivatives
IE851734L (en) Isoindolinyl-alkyl-piperazines
BG60207B2 (en) Process for preparing n-substituted 3-acyl-2-oxindole-1-carboxamides
EP0155055A3 (en) Stabilized polyolefinic compositions and stabilizer compounds suitable to that purpose
IE810728L (en) Pyrazole derivatives.
IE820239L (en) Carbapenem derivatives
EP0600092A4 (en) Thiazole derivative.
ATE97404T1 (de) Prostazyklin-(pgi2)-analoge.
IE39576B1 (en) Derivatives of 3-(p-chlorobenzoyl)-2-methyl-phenylacetic acid
IE791036L (en) Thienopyridines and furanopyridines
IE801789L (en) Nitrosourea derivatives.
IE802112L (en) Pyridine derivatives.
IE38141L (en) 3, 4-dihydropyridones.
KR840001154A (ko) 1,2-디티올-3-일리덴 암모늄 유도체의 제조방법